An anti-tumoral effect of chemerin independently from leukocyte recruitment is supported by a recent report in a model of adrenocortical carcinoma (55), in which chemerin was reported to inhibit cell proliferation by decreasing the activity of WNT/β-catenin and MAPK pathways in tumor cells. Here, RARRES2 is linked to neoplasm.